Hypertrichosis of the eyelashes caused by bimatoprost

Antonella Tosti, Massimiliano Pazzaglia, Stylianos Voudouris, Giovanni Tosti

Research output: Contribution to journalArticle

50 Scopus citations

Abstract

The phenyl-substituted analog of prostaglandin F 2alpha , latanoprost (Xalatan; Pfizer, Inc, New York, NY) is an intraocular pressure (IOP)-lowering drug for use in patients with glaucoma and ocular hypertension. Latanoprost has been shown to stimulate eyelash hypertrichosis and has recently been proposed as a possible treatment for alopecia areata involving the eyelashes. We report a case of hypertrichosis of the eyelashes caused by the prostamide bimatoprost (Lumigan; Allergan, Inc, Irvine, Calif), a new IOP-lowering drug.

Original languageEnglish (US)
Pages (from-to)S149-S150
JournalJournal of the American Academy of Dermatology
Volume51
Issue number5 SUPPL.
DOIs
StatePublished - Nov 2004
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Hypertrichosis of the eyelashes caused by bimatoprost'. Together they form a unique fingerprint.

  • Cite this